Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Dec 02, 2007

FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension

Nov 19, 2007

Mylan Completes $2.89 Billion of Equity Financings, Including Exercise of Overallotment Option of Mandatory Convertible Preferred Stock

Nov 14, 2007

Mylan Prices Offerings of Common Stock and Mandatory Convertible Preferred Stock

Nov 01, 2007

Mylan Launches Registered Offering of Common Stock and Mandatory Convertible Preferred Stock

Nov 01, 2007

Mylan Reports Adjusted Diluted Cash EPS of $0.31

Oct 30, 2007

Mylan Announces Appointment of Joseph F. Haggerty as Senior Vice President and Global General Counsel

Oct 23, 2007

Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline

Oct 04, 2007

Mylan Settles Its First-to-File Opportunity on Levetiracetam with UCB

Oct 04, 2007

Mylan Vice Chairman and CEO Robert J. Coury to Ring NYSE Closing Bell(R) in Celebration of Merck Generics Acquisition

Oct 02, 2007

Mylan Announces Management of Specialty Business, Dey L.P.

Pagination

First page
Previous page
…
Page 94
Page 95
Page 96
Page 97
Current page 98
Page 99
Page 100
Page 101
Page 102
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.